Matches 1 - 50 out of 196 1 2 3 4 >
Match Document Document Title
7612018 Insecticides  
Compounds of formula (I) wherein the substituents are as defined in claim 1 , and the agrochemically acceptable salts and all stereoisomers and tautomeric forms of the compounds of formula I can...
7605290 Processes for the synthesis of O-desmethylvenlafaxine  
The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine.
7597726 Mannich detergents for hydrocarbon fuels  
New, highly effective Mannich detergents for use in hydrocarbon fuels are described which reduce engine deposits in spark and compression ignition internal combustion engines. They are Mannich...
7576241 Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them  
A compound of the formula wherein the substituents are defined as in the specification useful as intermediates.
7563930 Crystal forms of Cinacalcet HCI and processes for their preparation  
Provided are crystalline forms of Cinacalet HCl and processes for their preparation.
7544312 Charge transport compositions and electronic devices made with such compositions  
The present invention relates to charge transport compositions. The invention further relates to electronic devices in which there is at least one active layer comprising such charge transport...
7514470 Aniline derivatives as selective androgen receptor modulators  
This invention relates to non-steroidal compounds that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of...
7491848 Process for making desvenlafaxine  
Desvenlafaxine is formed from venlafaxine by the use of a demethylating agent comprising a metal sulfide, such as sodium sulfide, and optionally selenium.
7468459 Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation  
The present invention relates to a process for the efficient preparation of enantiomerically enriched beta amino acid derivatives which are useful in the asymmetric synthesis of biologically active...
7435854 Methods for preparing O-desmethylvenlafaxine  
The present invention provides an efficient method of making O-desmethyl-venlafaxine.
7432399 Diols formed by ring-opening of epoxies  
A polyol monomer comprising the formula: R 1 and R 3 are —H, aliphatic, aromatic, or ether; R 2 is aliphatic, aromatic, ester, ether, or acrylic, and R 1 contains a hydroxyl group, R 3 ...
7408084 Process for producing optically active β-amino alcohol  
A process for easily producing an optically active β-amino alcohol useful as a pharmaceutical intermediate from an inexpensive, readily available starting material is provided. A readily available...
7405262 Preparation of functionalized anionic polymerization initiators  
A process for preparing a functionalized polymerization initiator, the process comprising combining a functionalized styryl compound and an organolithium compound.
7402698 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use  
The present invention is directed to secondary amino- and cycloamino-cycloalkanol derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment...
7390835 Aralkyl amines as cannabinoid receptor modulators  
Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases...
7384434 Reaction of phenols with intermediate triazines  
An improved process for preparing a Mannich product employs an intermediate or pre-formed triazine. The product is useful as a detergent in fuel compositions. The fuel compositions containing the...
7385064 Catalysts for use in enantioselective synthesis  
Disclosed are compounds having the following formula: in which Z 11 is selected from a substituted or unsubstituted saturated adamantyl or other polycyclic group and a substituted or...
7378552 Monoamine re-uptake inhibitors and methods relating thereto  
Monoamine re-uptake inhibitors and more specifically serotonin and noradrenaline re-uptake inhibitors are disclosed that have utility in the treatment of disorders of the central or peripheral...
7345202 Use of sulfamic acids as resolving agent  
The invention relates to the use of chiral sulfamic acids as resolving agents, the sulfamic acid having the formula (R 1 ,R 2 )N—SO3H, wherein: R 1 and R 2 , being the same or different,...
7345048 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors  
The invention relates to D-Ala-D-Ala ligase inhibitors having the formula: wherein R 1 is NH 2 ; R 2 is NH 2 ; R 3 is selected from hydrogen, alkyl, amino, hydroxy, alkoxy, and alkylamino;...
7342133 Substituted amino compounds as 5-HT/NA uptake inhibitors  
The invention relates to substituted amino compounds, to processes for their preparation, to pharmaceutical formulations containing these compounds and to the use of these substances in the...
7339079 Thyronamine derivatives and analogs and methods of use thereof  
Thyronamine derivatives and analogs, methods of using such compounds, and pharmaceutical compositions containing them are disclosed. Methods of preparing such compounds are also disclosed.
7332512 Halogenated nitrobutadienes for controlling animal pests  
The present invention relates to novel halonitrobutadienes, to processes for their preparation and to their use for controlling animal pests.
7297820 Stilbene derivatives and their use for binding and imaging amyloid plaques  
This invention relates to a method of imaging amyloid deposits and to labeled compounds, and methods of making labeled compounds useful in imaging amyloid deposits. This invention also relates to...
7288571 Thyroid receptor ligands and method II  
New thyroid receptor ligands are provided which have general formula (I) in which: n is an integer from 0 to 4; R 1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7...
7271291 1,3,5-tris (arylamino) benzenes  
The invention provides 1,3,5-tris(arylamino)benzenes represented by the general formula (I) wherein A is naphthyl, anthryl or phenanthryl group, and R is hydrogen atom or diarylamino group. ...
7253211 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity  
The invention relates to substituted aryl and heteroaryl (R)-Chiral Halogenated 1-Substitutedamino-(n+1)-Alkanol compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma...
7253189 Cannabinoid receptor ligands  
A compound of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein: R 1 , R 2 , L 1 , L 2 , M 1 , M 2 , n, p, q, A, D, X, Y and Z are as described in the specification;...
7250533 Process for preparing Cinacalcet hydrochloride  
Processes for preparing cinacalcet are provided.
7235576 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors  
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
7227040 Process for forming branched composition catalytically by carbon-hydrogen bond activation in a saturated moiety  
A branched composition can be formed by reacting a reagent containing a saturated hydrocarbon moiety in the presence of (a) a catalyst capable of activating a carbon-hydrogen bond therein and (b) a...
7226950 Sodium channel modulators  
The invention provides sodium channel modulating compounds which are useful for treating diseases or conditions associated with sodium channel activity, such as neuropathic pain. The invention also...
RE39530 3-amino-3-arylpropan-1-ol-compounds, their preparation and use  
3-amino-3-arylpropan-1-ol compounds corresponding to the formula I in which R 1 to R 5 , A and X have the meanings according to claim 1, and their preparation and use as medicaments.
7186864 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof  
A compound of Formula (IA) or Formula (IB) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical...
7144920 Polyamine analogs that activate antizyme frameshifting  
Novel polyamines, their synthesis and use in pharmacological, cosmetic or agricultural applications are provided. The polyamines induce antizyme production which in turn down regulates both the...
7141697 Process for the preparation of phenethylamine derivatives  
Disclosed is a process for the preparation of a compound of formula wherein R 1 is hydrogen, hydroxyl, or unsubstituted or substituted alkyl or alkoxy, R 2 is hydrogen or a substituent...
7109343 Metal catalysts and methods for making and using same  
Compounds having the formula: are disclosed. M 1 and M 2 are the same or different and are transition metal atoms or ions; Z 2 and Z 3 , independently, are the atoms necessary to complete a...
7105701 β2-adrenergic receptor agonists  
Disclosed are multibinding compounds which are β2-adrenergic receptor agonists and are useful in the treatment and prevention of respiratory diseases such as asthma, bronchitis. They are also...
7078567 Amination process  
The present invention provides methodology for carbon-nitrogen bond formation via vinyl or aryl amination. In the process of the invention, an sp 2 hybridized radical is reacted with an azomethine...
7074961 Antidepressants and their analogues as long-acting local anesthetics and analgesics  
Methods and compositions of antidepressants and analogs thereof for inducing local long-lasting anesthesia and analgesia are provided. The methods and compositions are useful for alleviating acute...
7074243 N-benzyl-m-phenylenediamine derivatives and dyes containing said compounds  
N-benzyl-m-phenylenediamine derivatives of general formula (I) or the physiologically tolerated, water-soluble salts thereof and dyeing agents for keratin fibers containing these compounds.
7045661 Crystalline forms of venlafaxine hydrochloride  
Crystalline forms of Venlafaxine hydrochloride were found, referred to hereinafter as polymorphic Forms A, B and D. Furthermore, the present invention is directed to processes for the preparation...
7037669 Assays for amphetamine and methamphetamine using stereospecific reagents  
Methods, compositions and kits are disclosed. Enzyme conjugates of Formula I may be employed in assays for the determination of an amphetamine and/or a methamphetamine. Immunogenic conjugates of...
7034176 Aminopropylphosphinic acids  
Intermediates used in the preparation of compounds of formula I, or a stereoisomer thereof, or a pharmaceutically acceptable form of either selected from the group consisting of a salt, a...
7030164 Crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof  
This invention relates to a highly thermally stable novel anhydrous crystalline polymorphic form of venlafaxine hydrochloride, methods for the preparation thereof, and its use.
7026513 Manufacture of phenyl ethylamine compounds, in particular venlafaxine  
A process for the preparation of hydroxy(cycloalkane/cyclokene) phenylethyl amine of the general formula (III) comprising alkylation of its precursor amine of general formula (II) which is in turn...
6991746 Polymeric allophanates of diphenylmethane diisocyanate, perpolymers of these polymeric allophanates, and processes for the preparation of the polymeric allophanates and the prepolymers thereof  
The present invention relates to a new high functionality MDI. In particular, this invention relates to polymeric allophanates based on diphenylmethane diisocyanate having an NCO group content of...
6960691 Production process for halogenated aromatic methylamine  
The invention intends to provide means for producing halogenated aromatic methylamine useful as an intermediate in the production of agrochemical or medical preparations, by an industrially...
6958418 Process for preparing vanillylamine hydrochloride  
Process for preparing vanillylamine or one of the salts thereof by reacting vanillin with hydroxylamine or the salts thereof in the presence of an organic salt, which may optionally be produced in...
6956132 Process for producing 2-phenylacetophenone derivatives and precursors therefor  
A process for producing 2-phenylacetophenone derivatives represented by the formula (I): (wherein X is an alkyl group or a haloalkyl group, and Y is a hydrogen atom, a halogen atom or an alkyl...
Matches 1 - 50 out of 196 1 2 3 4 >